FUNDING
Agency:
Hellenic Foundation for Research & Innovation (HFRI) ELIDEK
Grant ID:
25170
Duration:
2025-2028
Title:
In vivo CRISPR screens to decode Dendritic Cell 1 fate in tumours
Budget:
299.332,00 €
PI:
Maria Tsoumakidou
Agency:
European Commission - HORIZON EUROPE
Grant ID:
101158506
Duration:
2024 – 2026
Type:
HORIZON-WIDERA-2023-ACCESS-06 (Hop-on facility)
Role:
Principal Investigator
Title:
Delineating Responses to Respiratory Viral Infections Through Lung-on-Chip Modeling
Budget:
545.000 €
Agency:
European Research Council
Grant ID:
101088596
Duration:
2023-2028
Type:
Research Grant
Role:
PI
Title:
Artifying fibroblasts: Perturbation modelling in the lung tumor phase space to rewire fibroblasts for immunotherapy.
Budget:
1.999.250 €
Agency:
General Secretariat of Research and Innovation (GSRI)
Grant ID:
Τ2ΕΔΚ-02800
Duration:
2022-2024
Type:
Research Grant
Role:
PI
Title:
Development of tumor-on-chip platform for predicting lung cancer patient response to immunotherapy.
Budget:
332.850 €
Agency:
EraPerMed (ERA-Net Cofund, H2020 Grant Agreement No. 779282)
Grant ID:
ERAPERMED2019-217
Duration:
2020-2023
Type:
Transnational Synergy Research Grant
Role:
Coordinator
Title:
Proteomic screening of bronchoscopic biopsies-on-chip for improved prediction of anti-PD-1 responses in real-time.
Budget:
217.400 €
